Method of treating hyperlipidemia

Details Method of treating hyperlipidemia Method of treating hyperlipidemia

1998-05-13

1999-12-21

Russel, Jeffrey E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 16, 530311, A61K 3831

Patent

active

060049286

ABSTRACT:
The present invention relates to a method of decreasing body weight in a patient. The method includes the step of administering a therapeutically effective amount of a type-5 selective somatostatin agonist to the patient.

REFERENCES:
patent: 4133782 (1979-01-01), Vale, Jr. et al.
patent: 4146612 (1979-03-01), Veber
patent: 4190575 (1980-02-01), Sarantakis
patent: 4190648 (1980-02-01), Veber
patent: 4209426 (1980-06-01), Sarantakis
patent: 4211693 (1980-07-01), Rivier et al.
patent: 4215039 (1980-07-01), Sarantakis
patent: 4224199 (1980-09-01), Meyers et al.
patent: 4235886 (1980-11-01), Freidinger et al.
patent: 4238481 (1980-12-01), Rink et al.
patent: 4261885 (1981-04-01), Sakakibara et al.
patent: 4282143 (1981-08-01), Sarantakis
patent: 4291022 (1981-09-01), Sandrin et al.
patent: 4310518 (1982-01-01), Freidinger et al.
patent: 4316890 (1982-02-01), Kamber et al.
patent: 4328214 (1982-05-01), Rink et al.
patent: 4358439 (1982-11-01), Sieber et al.
patent: 4360516 (1982-11-01), Freidinger et al.
patent: 4369179 (1983-01-01), Rink et al.
patent: 4395403 (1983-07-01), Bauer et al.
patent: 4435385 (1984-03-01), Bauer et al.
patent: 4485101 (1984-11-01), Coy et al.
patent: 4486415 (1984-12-01), Freidinger
patent: 4522813 (1985-06-01), Nutt
patent: 4585755 (1986-04-01), Morgan et al.
patent: 4603120 (1986-07-01), Kamber
patent: 4650787 (1987-03-01), Schally et al.
patent: 4684620 (1987-08-01), Hurby et al.
patent: 4725577 (1988-02-01), Schally et al.
patent: 4728638 (1988-03-01), Bauer et al.
patent: 4853371 (1989-08-01), Coy et al.
patent: 4871717 (1989-10-01), Coy et al.
patent: 4904642 (1990-02-01), Coy et al.
patent: 5506339 (1996-04-01), Coy et al.
patent: 5763200 (1998-06-01), Dunmore et al.
Van Binst, G., et al., Peptide Research 5(1), pp. 8-13 (1992).
Horvath, A., et al., 22nd Annual European Peptide Symposium, Sep. 13-19, 1992, Interlaken, Switzer, pp. 533-534.
R. Cohen et al., Horm Metab. Res. 24 (1992), pp. 397-400.
Moller et al., Clin. Science, (1988), 75. pp. 345-350.
Fukushima et al., Endocrinol, Japan, 1985 32 (2), 241-248.
Bruno et al., Proc. Nat'l Acad. Science,, USA, vol. 89, pp. 11151-11155., (1992).
Martin et al., Life Sci, V. 35 pp. 2627-2633. (1984).
"Carbohydrate Tolerance and Serum Lipids in Acromegaly Before and During Treatment with High Dose Octreotide", James et al., Diabet Med (England) Jul. 1991, 8 (6) pp. 517-523.
Caplus An 1997; 9328, Dunmore et al., WO9635950, abstract Date: 1996.
Drugu An 95: 40459, Davenport et al., Diabetologia, (38 Suppl. 1, A106), abstract.

Affiliated with

Also associated with

Rating

Method of treating hyperlipidemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating hyperlipidemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating hyperlipidemia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-505086